Agonistic Antibodies Directed at the Angiotensin II, AT1 Receptor in Preeclampsia
- 1 February 2006
- journal article
- review article
- Published by Springer Nature in Journal of the Society for Gynecologic Investigation
- Vol. 13 (2) , 79-86
- https://doi.org/10.1016/j.jsgi.2005.11.006
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trialThe Lancet, 2002
- Pathophysiology of Preeclampsia: Linking Placental Ischemia/Hypoxia with Microvascular DysfunctionMicrocirculation, 2002
- Recent Insights into the Pathogenesis of Pre-eclampsiaPlacenta, 2002
- Diagnosis and management of preeclampsia and eclampsiaInternational Journal of Gynecology & Obstetrics, 2002
- The Placenta DilemmaSeminars in Reproductive Medicine, 2000
- The myths of laparoscopic surgeryAmerican Journal of Obstetrics and Gynecology, 2000
- Preeclampsia: What we know and what we do not knowSeminars in Perinatology, 2000
- The pathogenesis of pre-eclampsia: new aspectsjpme, 2000
- Risk Factors for PreeclampsiaClinical Obstetrics and Gynecology, 1999
- Effect of Low-Dose Aspirin on Fetal and Maternal Generation of Thromboxane by Platelets in Women at Risk for Ppregnancy-Induced HypertensionNew England Journal of Medicine, 1989